- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Bladder Small Cell Neuroendocrine Carcinoma
Total 8918 results
-
Daiichi SankyoAstraZenecaAvailableAdvanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMetastatic Non Small Cell Lung Cancer | Recurrent Non Small Cell Lung CancerUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueANRS, Emerging Infectious DiseasesCompletedHIV/AIDS | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticFrance
-
Chonnam National University HospitalRoche Pharma AGCompletedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentKorea, Republic of
-
Fox Chase Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentUnited States
-
Centre Hospitalier Intercommunal CreteilGroupe Français de Pneumo-CancérologieTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Cerebral Metastases | Adenocarcinoma of Lung Metastatic to BrainFrance
-
Charles KunosNational Center for Advancing Translational Sciences (NCATS)CompletedLarge-Cell Neuroendocrine CarcinomaUnited States
-
AmgenNot yet recruitingAdvanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced or Metastatic Non-squamous Non-small-cell Lung Cancer
-
GenmabMerck Sharp & Dohme LLC; BioNTech SERecruitingNon Small Cell Lung Cancer MetastaticUnited States, Spain, Netherlands, Italy, France, United Kingdom, Poland, Germany, Portugal
-
Iovance Biotherapeutics, Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States, Canada, Germany, Netherlands, Switzerland
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer Metastatic | Targetable Oncogenes (EGFR, ALK, ROS1)United States
-
AmgenParexelWithdrawnMetastatic Non-small Cell Lung Cancer (NSCLC) | Non-squamous NSCLC
-
Eli Lilly and CompanyCompletedNon-small Cell Lung Cancer MetastaticJapan
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedNon-small Cell Lung Cancer MetastaticChina
-
Taizhou HospitalUnknownNon Small Cell Lung Cancer Metastatic
-
University of Alabama at BirminghamSanofiCompletedNon-small Cell Lung Cancer (NSCLC) | Metastatic NSCLC | Stage IV NSCLCUnited States
-
Hoffmann-La RocheCompletedNon-small Cell Lung Cancer MetastaticRomania
-
AstraZenecaCompletedNewly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung CancerGermany
-
Anchiano Therapeutics Israel Ltd.CompletedTransitional Cell Carcinoma of BladderIsrael
-
Zetiq TechnologiesUnknownEvaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine CytologyBladder Cancer Transitional Cell CarcinomaIsrael
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Qianfoshan HospitalRecruitingMetastatic NSCLC | Locally Advanced Non-Small Cell Lung CancerChina
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingRelapsed or Metastatic Non-small Cell Lung CancerChina
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Sichuan Cancer Hospital and Research InstituteMianyang Central Hospital; Cancer Hospital of Guizhou ProvinceUnknownOligo-metastatic Stage IV Non-small Cell Lung CancerChina
-
Vaxon BiotechCompletedNon-small Cell Lung Cancer MetastaticGermany, Greece, Spain, Romania, France, Italy, Czechia, Poland
-
Sierra Oncology, Inc.TerminatedRelapsed Metastatic KRAS-Mutated Non-Small Cell Lung CancerUnited States
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Memgen, Inc.H. Lee Moffitt Cancer Center and Research Institute; Duke Cancer InstituteRecruitingMelanoma | Head and Neck Cancer | Pancreatic Cancer | Solid Tumor | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Cancer | Merkel Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Lymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Neoplasm Metastasis | Hodgkin Disease | Pancreatic Adenocarcinoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head... and other conditionsUnited States
-
Jacobio Pharmaceuticals Co., Ltd.Not yet recruitingAdvanced Non-squamous Non-small-cell Lung Cancer | Metastatic Non-squamous Non Small Cell Lung Cancer
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Jeffrey ClarkeMerck Sharp & Dohme LLC; Grid TherapeuticsSuspendedNon Small Cell Lung Cancer | Metastatic NSCLC | Recurrent Non Small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung CancerUnited States
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand
-
National Cancer Institute (NCI)RecruitingMetastatic Merkel Cell Carcinoma | Refractory Merkel Cell Carcinoma | Locally Advanced Merkel Cell Carcinoma | Unresectable Merkel Cell Carcinoma | Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8United States
-
TransgeneMerck Sharp & Dohme LLC; BioInvent International ABRecruitingMelanoma | Soft Tissue Sarcoma | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Merkel Cell CarcinomaFrance, Belgium
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlatinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Extensive Stage Lung Small Cell Carcinoma | Refractory Extensive Stage Lung Small Cell CarcinomaUnited States
-
Case Comprehensive Cancer CenterPfizerTerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Beth Israel Medical CenterSt. Luke's-Roosevelt Hospital CenterTerminatedNonsquamous Nonsmall Cell Neoplasm of Lung | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB/IVUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Tata Memorial HospitalRecruitingOligometastatic Disease | Metastatic Non Small Cell Lung CancerIndia
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, United States, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Netherlands, Philippines, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel
-
AstraZenecaParexelActive, not recruitingAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, Romania, Canada, Korea, Republic of, Brazil, Hungary, Japan, China, Taiwan, Hong Kong, United Kingdom, Germany, Poland, Australia, Netherlands, Serbia, India, Argentina, Ireland